loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 21964 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 METHYLNALTREXONE BROMIDE (3)

filter

01 SALIX PHARMS (3)

filter

01 SOLUTION;SUBCUTANEOUS (3)

filter

01 12MG/0.6ML (12MG/0.6ML) (2)

02 8MG/0.4ML (8MG/0.4ML) (1)

filter

01 USA (3)

URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
12MG/0.6ML (12MG/0.6ML...
RELISTOR
USA
21964
2008-04-24
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
8MG/0.4ML (8MG/0.4ML)
RELISTOR
USA
21964
2010-09-27
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
12MG/0.6ML (12MG/0.6ML...
RELISTOR
USA
21964
2010-09-27
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 21964

Looking for CTD TGA MCC DOSSIER APPLICATION 21964 3

19

Salix Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is METHYLNALTREXONE BROMIDE, with a corresponding application number 21964 and regulatory information .

proudly manufactured in the

approval since 2008-04-24

Salix Pharmaceuticals's RELISTOR SOLUTION;SUBCUTANEOUS, medication with 12MG/0.6ML (12MG/0.6ML) of METHYLNALTREXONE BROMIDE.

18

Salix Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is METHYLNALTREXONE BROMIDE, with a corresponding application number 21964 and regulatory information .

proudly manufactured in the

approval since 2010-09-27

Salix Pharmaceuticals's RELISTOR SOLUTION;SUBCUTANEOUS, medication with 8MG/0.4ML (8MG/0.4ML) of METHYLNALTREXONE BROMIDE.

17

Salix Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is METHYLNALTREXONE BROMIDE, with a corresponding application number 21964 and regulatory information .

proudly manufactured in the

approval since 2010-09-27

Salix Pharmaceuticals's RELISTOR SOLUTION;SUBCUTANEOUS, medication with 12MG/0.6ML (12MG/0.6ML) of METHYLNALTREXONE BROMIDE.

Post Enquiry
POST ENQUIRY